International Consultation on Incontinence Questionnaire Under Active Bladder (ICIQ-UAB)

The ICIQ -UAB is the first patient reported outcome (PRO) measure for the assessment of the symptoms and impact on health-related quality of life of underactive bladder (UAB), developed in-line with the Food and Drug Administration (FDA) Guidance for Industry. It is currently in further development.

Associated publications:
Uren, A. Cotterill, N. Harding, C. et al. The development of the ICIQ-UAB: A patient reported outcome measure for underactive bladder. Neurourology and Urodynamics. 2019;1-9

Uren AD, Cotterill N, Harding C, et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol. 2017;72(3):402-407.